GWM
REGN icon

GK Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

GK Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+337
New +$229K 0.11% 212
2026
Q1 		– Sell
-320
Closed -$247K – 163
2025
Q4 		$247K Buy
+320
New +$217K 0.16% 147

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GK Wealth Management's REGN Position: Q2 2026 in Review

GK Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 337 shares worth $210K. The stake represents 0.11% of the portfolio and ranks #212 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in REGN as recently as Q4 2025.

GK Wealth Management first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $247K in Q4 2025. 180 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • GK Wealth Management held 337 shares of Regeneron Pharmaceuticals worth $210K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new GK Wealth Management position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.11% of GK Wealth Management's portfolio in Q2 2026, its #212 holding.
  • GK Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • GK Wealth Management's Regeneron Pharmaceuticals position peaked at $247K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.